Journal article
The role of technology in clinical trials using stereotactic body radiotherapy.
- Abstract:
- Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR). While some technological challenges remain, the crucial point for the next generation of SABR clinical trials is that today’s technology is used correctly and close to its optimal potential for accuracy. The credentialing procedure of SABR needs to be extensive, but this investment will benefit the trial itself, the patients and the professionals involved.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 455.0KB, Terms of use)
-
- Publisher copy:
- 10.1259/bjr.20160930
Authors
- Publisher:
- British Institute of Radiology
- Journal:
- British Journal of Radiology More from this journal
- Volume:
- 90
- Issue:
- 1071
- Pages:
- 20160930
- Publication date:
- 2017-03-01
- Acceptance date:
- 2017-01-01
- DOI:
- ISSN:
-
1748-880X
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:668880
- UUID:
-
uuid:4f6b11d7-0f1d-4760-8fb3-7d92b15b7d41
- Local pid:
-
pubs:668880
- Source identifiers:
-
668880
- Deposit date:
-
2017-03-08
Terms of use
- Copyright holder:
- Aznar et al
- Copyright date:
- 2017
- Notes:
- © 2017 The Authors. Published by the British Institute of Radiology under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License http://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted non-commercial reuse, provided the original author and source are credited.
If you are the owner of this record, you can report an update to it here: Report update to this record